EMBO Molecular Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 7.9 | Q1 | 87.4% | 3.277 | Q1 | 97.9% |
| 2024 | 8.3 | Q1 | 89.7% | 3.571 | Q1 | 98.3% |
| 2023 | 9.0 | Q1 | 91.4% | 3.964 | Q1 | 98.7% |
| 2022 | 11.1 | Q1 | 93.2% | 3.932 | Q1 | 98.7% |
| 2021 | 14.3 | Q1 | 94.6% | 4.039 | Q1 | 98.8% |
| 2020 | — | — | 4.923 | Q1 | 99.0% | |
| 2019 | — | — | 4.816 | Q1 | 99.0% | |
| 2018 | — | — | 5.033 | Q1 | 99.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1757-4684
ISSN
1757-4676
country
DEcoverage
2009-2026